Skip to main content
Georgia Cancer Info Logo
Donate
Georgia Cancer Info Logo
About Georgia CORENews & HappeningsWays to Give
Advancing ResearchExplore Clinical TrialsCollaboration Opportunities
ScreeningGeorgia Genetics ProgramEducation & NavigationSurvivorship

Check your hereditary breast & ovarian cancer risk with our easy Genetic Screening Tool.

Start risk assessment
Search ResourcesFind Cancer Centers
Donate
Georgia Cancer Info Logo

Contact us

+1-404-523-8735info@georgiacancerinfo.org
999 Peachtree St NE, Suite 400Atlanta, GA 30309

Sign up for news and announcements

  • Home
  • About
  • Contact
  • Facebook
  • LinkedIn
  • Instagram

© 2005 - 2026 Georgia Center for Oncology Research and Education. All Rights Reserved.

PrivacyTerms & Conditions
Roland Matthews, MD
  1. About Us/
  2. Roland Matthews, MD

Roland Matthews, MD

Immediate Past Chair

Associate Professor, Morehouse School of Medicine

Dr. Roland Matthews is chairman of the Department of Obstetrics and Gynecology at the Morehouse School of Medicine, and a gynecologic oncologist and attending physician at Grady Memorial Hospital in Atlanta. Dr. Matthews is an executive committee member of the State University of New York Stony Brook School of Medicine (SUNY) Health Science Center in Brooklyn, New York, where he received his Doctor of Medicine. He completed a residency in Obstetrics and Gynecology and a fellowship at the State University of New York Downstate Medical Center in Brooklyn. He is board-certified in Gynecologic Oncology. Dr. Matthews is Georgia Cancer Coalition (GCC) Distinguished Cancer Scholar, investigating the role of prohibitin in cervical cancer.

Roland Matthews, MD

Keep up to date with Georgia CORE on LinkedIn

Real stories from patients, survivors, and advocates across Georgia.

Follow on LinkedIn
Oct. stakeholder session: Should Georgia have a cancer clinical trials roundtable?

Day 2 of an impressive convening of Georgia CORE partners representing the cancer research, care provider, patient navigation and advocacy communities. Each stakeholder session was an opportunity for these groups to come together and discuss how to carry the recommendations forward of the Georgia House Study Committee on Access to Cancer Care on day 1; and the state of cancer clinical trials in Georgia on day 2. Be on the look out for the forthcoming report of these impactful two days!